Long-term survival in patients hospitalized with congestive heart failure: Relation to preserved and reduced left ventricular systolic function

European Heart Journal

Volumn 24, Issue 9, 2003, Pages 863-870

  Gustafsson, Finn ^a   Torp Pedersen, Christian ^b   Brendorp, Bente ^b   Seibæk, Marie ^b   Burchardt, Hans ^b   Køber, Lars ^c  

^a FREDERIKSBERG HOSPITAL   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c Rigshospitalet   (Denmark)

Author keywords

Diastolic dysfunction; Ejection fraction; Mortality; Myocardial infarction; Prognosis

Indexed keywords

ADULT; AGE; AGED; ANAMNESIS; ARTICLE; CLINICAL TRIAL; COMORBIDITY; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DEATH; DENMARK; DOUBLE BLIND PROCEDURE; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; GENDER; HEART LEFT VENTRICLE CONTRACTION; HEART MUSCLE ISCHEMIA; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SCORING SYSTEM; SEX DIFFERENCE; SURVIVAL TIME;

AGED; COHORT STUDIES; CONFIDENCE INTERVALS; FEMALE; HEART FAILURE, CONGESTIVE; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; MALE; PROGNOSIS; SURVIVAL ANALYSIS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0037965969     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0195-668X(02)00845-X     Document Type: Article

References (43)

1. Vasan RS, Larson MG, Benjamin EJ et al. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol 1999;33:1948-55.
2. Senni M, Tribouilloy CM, Rodeheffer RJ et al. Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991. Circulation 1998;98:2282-9.
3. Johnson G, Carson P, Francis GS et al. Influence of prerandomization (baseline) variables on mortality and on the reduction of mortality by enalapril. Veterans affairs cooperative study on vasodilator therapy of heart failure (V-HeFT II). V-HeFT VA Cooperative Studies Group. Circulation 1993;87:VI32-9.
4. Aronow WS, Ahn C, Kronzon I. Prognosis of congestive heart failure after prior myocardial infarction in older men and women with abnormal versus normal left ventricular ejection fraction. Am J Cardiol 2000;85:1382-4.
5. McDermott MM, Feinglass J, Lee PI et al. Systolic function, readmission rates, and survival among consecutively hospitalized patients with congestive heart failure. Am Heart J 1997;134:728-36.
6. Pernenkil R, Vinson JM, Shah AS et al. Course and prognosis in patients > or =70 years of age with congestive heart failure and normal versus abnormal left ventricular ejection fraction. Am J Cardiol 1997;79:216-9.
7. Cowie MR, Wood DA, Coats AJ et al. Survival of patients with a new diagnosis of heart failure: a population based study. Heart 2000;83:505-10.
8. Madsen BK, Hansen JF, Stokholm KH et al. Chronic congestive heart failure. Description and survival of 190 consecutive patients with a diagnosis of chronic congestive heart failure based on clinical signs and symptoms. Eur Heart J 1994;15:303-10.
9. Tsutsui H, Tsuchihashi M, Takeshita A. Mortality and readmission of hospitalized patients with congestive heart failure and preserved versus depressed systolic function. Am J Cardiol 2001;88:530-3.
10. Philbin EF, Rocco TA Jr, Lindenmuth NW et al. Systolic versus diastolic heart failure in community practice: clinical features, outcomes, and the use of angiotensin-converting enzyme inhibitors. Am J Med 2000;109:605-13.
11. Chin MH, Goldman L. Correlates of major complications or death in patients admitted to the hospital with congestive heart failure. Arch Intern Med 1996;156:1814-20.
12. Philbin EF, Rocco TAJ, Lindenmuth NW et al. Clinical outcomes in heart failure: report from a community hospital-based registry. Am J Med 1999;107:549-55.
13. Stevenson WG, Stevenson LW, Middlekauff HR et al. Improving survival for patients with advanced heart failure: a study of 737 consecutive patients. J Am Coll Cardiol 1995;26:1417-23.
14. Zannad F, Braincon S, Juilliere Y et al. Incidence, clinical and etiologic features, and outcomes of advanced chronic heart failure: the EPICAL Study. Epidemiologie de l'Insuffisance Cardiaque Avancee en Lorraine. J Am Coll Cardiol 1999;33:734-42.
15. Saxon LA, Stevenson WG, Middlekauff HR et al. Predicting death from progressive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1993;72:62-5.
16. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group. Dofetilide in patients with left ventricular dysfunction and either heart failure or acute myocardial infarction: rationale, design, and patient characteristics of the DIAMOND studies. Clin Cardiol 1997;20:704-10.
17. Torp-Pedersen C, Moller M, Bloch-Thomsen PE et al. Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group. N Engl J Med 1999;341:857-65.
18. Kober L, Torp-Pedersen C, Carlsen J et al. An echocardiographic method for selecting high risk patients shortly after acute myocardial infarction, for inclusion in multi-centre studies (as used in the TRACE study). TRAndolapril Cardiac Evaluation. Eur Heart J 1994;15:1616-20.
19. Schiller NB, Shah PM, Crawford M et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2:358-67.
20. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
21. Jaagosild P, Dawson NV, Thomas C et al. Outcomes of acute exacerbation of severe congestive heart failure: quality of life, resource use, and survival. SUPPORT Investigators. The Study to Understand Prognosis and Preferences for Outcomes and Risks of Treatments. Arch Intern Med 1998;158:1081-9.
22. Ho KK, Anderson KM, Kannel WB et al. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation 1993;88:107-15.
23. Cowie MR, Wood DA, Coats AJ et al. Incidence and aetiology of heart failure; a population-based study. Eur Heart J 1999;20:421-8.
24. Davies MK, Hobbs FDR, Davis RC et al. Prevalence of left-ventricular dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study. Lancet 2001;358:439-44.
25. Figulla HR, Kellermann AB, Stille-Siegener M et al. Significance of coronary angiography, left heart catheterization, and endomyocardial biopsy for the diagnosis of idiopathic dilated cardiomyopathy. Am Heart J 1992;124:1251-7.
26. Andersson B, Waagstein F. Spectrum and outcome of congestive heart failure in a hospitalized population. Am Heart J 1993;126:632-40.
27. Johnstone D, Limacher M, Rousseau M et al. Clinical characteristics of patients in studies of left ventricular dysfunction (SOLVD). Am J Cardiol 1992;70:894-900.
28. McKee PA, Castelli WP, McNamara PM et al. The natural history of congestive heart failure: the Framingham study. N Engl J Med 1971;285:1441-6.
29. Cohen-Solal A, Desnos M, Delahaye F et al. A national survey of heart failure in French hospitals. The Myocardiopathy and Heart Failure Working Group of the French Society of Cardiology, the National College of General Hospital Cardiologists and the French Geriatrics Society. Eur Heart J 2000;21:763-9.
30. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 1999;353:9-13.
31. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999;353:2001-7.
32. Packer M, Coats AJ, Fowler MB et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001;344:1651-8.
33. Heidenreich PA, Lee TT, Massie BM. Effect of beta-blockade on mortality in patients with heart failure: a meta-analysis of randomized clinical trials. J Am Coll Cardiol 1997;30:27-34.
34. Chin MH, Goldman L. Gender differences in 1-year survival and quality of life among patients admitted with congestive heart failure. Med Care 1998;36:1033-46.
35. MacIntyre K, Capewell S, Stewart S et al. Evidence of improving prognosis in heart failure: trends in case fatality in 66 547 patients hospitalized between 1986 and 1995. Circulation 2000;102:1126-31.
36. Jong P, Vowinckel E, Liu PP et al. Prognosis and determinants of survival in patients newly hospitalized for heart failure: a population-based study. Arch Intern Med 2002;162:1689-94.
37. Dauterman KW, Go AS, Rowell R et al. Congestive heart failure with preserved systolic function in a statewide sample of community hospitals. J Card Fail 2001;7:221-8.
38. Wong M, Johnson G, Shabetai R et al. Echocardiographic variables as prognostic indicators and therapeutic monitors in chronic congestive heart failure. Veterans Affairs cooperative studies V-HeFT I and II. V-HeFT VA Cooperative Studies Group. Circulation 1993;87:VI65-70.
39. Ghali JK, Kadakia S, Bhatt A et al. Survival of heart failure patients with preserved versus impaired systolic function: the prognostic implication of blood pressure. Am Heart J 1992;123:993-7.
40. Taffet GE, Teasdale TA, Bleyer AJ et al. Survival of elderly men with congestive heart failure. Age Ageing 1992;21:49-55.
41. Senni M, Redfield MM. Heart failure with preserved systolic function. A different natural history? J Am Coll Cardiol 2001;38:1277-82.
42. Swedberg K, Pfeffer M, Granger C et al. Candesartan in heart failure-assessment of reduction in mortality and morbidity (CHARM): rationale and design. Charm-Programme Investigators. J Card Fail 1999;5:276-82.
43. Cleland JG, Tendera M, Adamus J et al. Perindopril for elderly people with chronic heart failure: the PEP-CHF study. The PEP Investigators. Eur J Heart Fail 1999;1:211-7.